Sector dividends Bolt Biotherapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 15/05/2026 BST			5-day change	1st Jan Change
4.780 ^USD	-4.40%		+2.36%	-12.58%

05-12	Bolt Biotherapeutics reports first quarter 2026 financial results	RE
05-12	Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (Y)	Dividend Yield (Y+1)	P/E (Y)	Price to Book (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Capi.($)
BOLT BIOTHERAPEUTICS, INC.	-	-	-0.36x	-	-	-	-	9.19M
ARGENX SE	0.06%	0.12%	29.67x	5.61x	7.59x	22.75x	23.51x	50.1B
WUXI APPTEC CO., LTD.	1.74%	1.95%	17.07x	3.29x	5.18x	11.33x	13.06x	45.82B
INSMED INCORPORATED	-.--%	-.--%	-40.59x	63.27x	13.55x	-36.8x	-43.29x	23.66B
BIONTECH SE	-.--%	-.--%	-17.88x	1.04x	3.19x	-5.8x	-4.58x	22.65B
WUXI BIOLOGICS (CAYMAN) INC.	-.--%	-.--%	22.1x	2.17x	4.38x	11.36x	13.67x	17.8B
GENMAB A/S	-.--%	-.--%	22.89x	2.56x	4.47x	14.73x	16.59x	16.08B
AKESO, INC.	-.--%	0.02%	749.62x	10.86x	17.63x	96.27x	201.98x	14.14B
SUMMIT THERAPEUTICS INC.	-.--%	-.--%	-14.77x	175.88x	3784.25x	-18.76x	-15.19x	13.09B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-.--%	-.--%	-440.28x	18x	31.6x	-1979.01x	-311.05x	13B
EXELIXIS, INC.	-.--%	-.--%	15.87x	4.49x	4.56x	10.68x	11.76x	12.6B
MADRIGAL PHARMACEUTICALS, INC.	-.--%	-.--%	-76.7x	26.86x	7.72x	-72.77x	-56.68x	12.07B
ARROWHEAD PHARMACEUTICALS, INC.	-.--%	-.--%	-23.4x	24.95x	22.11x	-28.37x	-22.96x	10.8B
PHARMAESSENTIA CORPORATION	0.2%	0.24%	35.65x	7.84x	11.35x	30.76x	27.1x	9.73B
REMEGEN CO., LTD.	-.--%	-.--%	12.36x	6.09x	7.44x	12.41x	11.35x	8.32B
NUVALENT, INC.	-.--%	-.--%	-17.85x	6.84x	581.38x	-16.84x	-16.63x	8.08B
VAXCYTE, INC.	-.--%	-.--%	-6.15x	-	-	-6.31x	-5.8x	7.56B
BIOCON LIMITED	0.12%	0.17%	118.09x	2.38x	4.72x	23.43x	51.14x	7.26B
Average	0.13%	0.15%	21.41x	22.63x	281.94x	-113.58x	-6.24x	16.26B
Weighted average by Cap.	0.29%	0.34%	22.14x	19.54x	198.69x	-82.60x	-1.58x